MedPage Today on MSN
Lyme disease vaccine candidate just misses its mark in late-stage trial
But a modified intent-to-treat analysis showed a noninferior vaccine efficacy rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results